Specific biomarkers associated with neurological complications and congenital central nervous system abnormalities from Zika virus-infected patients in Brazil

Journal of Infectious Diseases

Volumn 216, Issue 2, 2017, Pages 172-181

  Kam, Yiu Wing ^a   Leite, Juliana Almeida ^b   Lum, Fok Moon ^a   Tan, Jeslin J L ^a   Lee, Bernett ^a   Judice, Carla C ^b   De Toledo Teixeira, Daniel Augusto ^b   Andreata Santos, Robert ^c   Vinolo, Marco A ^b   Angerami, Rodrigo ^d   Resende, Mariangela Ribeiro ^b   Freitas, Andre Ricardo Ribas ^b   Amaral, Eliana ^e   Passini, Renato ^e   Costa, Maria Laura ^e   Guida, José Paulo ^e   Arns, Clarice Weis ^b   Ferreira, Luis Carlos S ^c   Rénia, Laurent ^a   Proença Modena, Jose Luiz ^b   Ng, Lisa F P ^a,f   Costa, Fabio T M ^b   more..

^a AGENCY FOR SCIENCE   (Singapore)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d Hospital of Clinics   (Brazil)

^e Campinas Department of Public Health Surveillance   (Brazil)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Congenital CNS deformities; Cytokines and biomarkers; Zika virus

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; CXCL1 CHEMOKINE; EOTAXIN; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LEUKEMIA INHIBITORY FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; SCATTER FACTOR; STEM CELL FACTOR; TUMOR NECROSIS FACTOR; CYTOKINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CENTRAL NERVOUS SYSTEM MALFORMATION; CHILD; CLINICAL FEATURE; CLINICAL OBSERVATION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HOSPITALIZATION; HUMAN; INFANT; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MALE; MENINGOENCEPHALITIS; MICROCEPHALY; NEUROLOGICAL COMPLICATION; NEWBORN; PARAPLEGIA; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RASH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZIKA FEVER; BLOOD; COMPLICATION; MIDDLE AGED; NERVOUS SYSTEM MALFORMATIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; VERY ELDERLY; VIROLOGY; VIRUS LOAD; YOUNG ADULT; ZIKA VIRUS; ZIKA VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; BRAZIL; CHILD; CYTOKINES; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INFANT, NEWBORN; MALE; MIDDLE AGED; NERVOUS SYSTEM MALFORMATIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; VIRAL LOAD; YOUNG ADULT; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85028375112     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jix261     Document Type: Article

References (38)

1. Dick GW, Kitchen SF, Haddow AJ. Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg 1952; 46:509-20.
2. Cao-Lormeau VM, Roche C, Teissier A, et al. Zika virus, French polynesia, South Pacific, 2013. Emerg Infect Dis 2014; 20:1085-6.
3. Musso D, Nilles EJ, Cao-Lormeau VM. Rapid spread of emerging Zika virus in the Pacific area. Clin Microbiol Infect 2014; 20:O595-6.
4. Campos GS, Bandeira AC, Sardi SI. Zika virus outbreak, Bahia, Brazil. Emerg Infect Dis 2015; 21:1885-6.
5. Enfissi A, Codrington J, Roosblad J, Kazanji M, Rousset D. Zika virus genome from the Americas. Lancet 2016; 387:227-8.
6. Hennessey M, Fischer M, Staples JE. Zika virus spreads to new areas-Region of the Americas, May 2015-January 2016. MMWR Morb Mortal Wkly Rep 2016; 65:55-8.
7. Duffy MR, Chen TH, Hancock WT, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 2009; 360:2536-43.
8. Oehler E, Watrin L, Larre P, et al. Zika virus infection complicated by Guillain-Barre syndrome-case report, French Polynesia, December 2013. Euro Surveill 2014; 19.
9. Cao-Lormeau VM, Blake A, Mons S, et al. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: A case-control study. Lancet 2016; 387:1531-9.
10. Schuler-Faccini L, Ribeiro EM, Feitosa IM, et al. Possible association between Zika virus infection and microcephaly-Brazil, 2015. MMWR Morb Mortal Wkly Rep 2016; 65:59-62.
11. Mlakar J, Korva M, Tul N, et al. Zika virus associated with microcephaly. N Engl J Med 2016; 374:951-8.
12. Cugola FR, Fernandes IR, Russo FB, et al. The Brazilian Zika virus strain causes birth defects in experimental models. Nature 2016; 534:267-71.
13. Wu KY, Zuo GL, Li XF, et al. Vertical transmission of Zika virus targeting the radial glial cells affects cortex development of offspring mice. Cell Res 2016; 26:645-54.
14. Suwanmanee S, Luplertlop N. Dengue and Zika viruses: lessons learned from the similarities between these Aedes mosquito-vectored arboviruses. J Microbiol 2017; 55:81-9.
15. Lanciotti RS, Kosoy OL, Laven JJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 2008; 14:1232-9.
16. Oliveira DB, Almeida FJ, Durigon EL, et al. Prolonged shedding of Zika virus associated with congenital infection. N Engl J Med 2016; 375:1202-4.
17. World Health Organization. Laboratory testing for Zika virus infection: interim guidance. WHO/ZIKV/LAB/16.1. Geneva, Switzerland: WHO Press, 2016; 1-4.
18. Jeong YE, Cha GW, Cho JE, Lee EJ, Jee Y, Lee WJ. Viral and serological kinetics in Zika virus-infected patients in South Korea. Virol J 2017; 14:70.
19. Bingham AM, Cone M, Mock V, et al. Comparison of test results for Zika virus RNA in urine, serum, and saliva specimens from persons with travel-associated Zika virus disease-Florida, 2016. MMWR Morb Mortal Wkly Rep 2016; 65: 475-8.
20. Lustig Y, Zelena H, Venturi G, et al. Sensitivity and kinetics of a NS1-based Zika virus ELISA in Zika infected travelers from Israel, Czech Republic, Italy, Belgium, Germany and Chile. J Clin Microbiol 2017; 55:1894-1901.
21. Steinhagen K, Probst C, Radzimski C, et al. Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: A multicohort study of assay performance, 2015 to 2016. Euro Surveill 2016; 21:30426.
22. Martina BE, Koraka P, Osterhaus AD. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 2009; 22:564-81.
23. Pan American Health Organization/World Health Organization. Zika-epidemiological report Brazil. March 2017. Washington, DC: PAHO/WHO; 2017.
24. Ferguson NM, Cucunubá ZM, Dorigatti I, et al. EPIDEMIOLOGY: countering the Zika epidemic in Latin America. Science 2016; 353:353-4.
25. Tappe D, Pérez-Girón JV, Zammarchi L, et al. Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase. Med Microbiol Immunol 2016; 205: 269-73.
26. Her Z, Kam YW, Gan VC, et al; SIgN Immunomonitoring Platform. Severity of plasma leakage is associated with high levels of interferon γ-inducible protein 10, hepatocyte growth factor, matrix metalloproteinase 2 (MMP-2), and MMP-9 during dengue virus infection. J Infect Dis 2017; 215:42-51.
27. Cheng YL, Lin YS, Chen CL, et al. Dengue virus infection causes the activation of distinct NF-κB pathways for inducible nitric oxide synthase and TNF-α expression in RAW264.7 cells. Mediators Inflamm 2015; 2015:274025.
28. Lum FM, Low DK, Fan Y, et al. Zika virus infects human fetal brain microglia and induces inflammation. Clin Infect Dis 2017; 64:914-20.
29. Liu Q, Zhou YH, Yang ZQ. The cytokine storm of severe influenza and development of immunomodulatory therapy. Cell Mol Immunol 2016; 13:3-10.
30. Chaix J, Tessmer MS, Hoebe K, et al. Cutting edge: priming of NK cells by IL-18. J Immunol 2008; 181:1627-31.
31. Poli A, Kmiecik J, Domingues O, et al. NK cells in central nervous system disorders. J Immunol 2013; 190:5355-62.
32. Li F, Wang Y, Yu L, et al. Viral infection of the central nervous system and neuroinflammation precede blood-brain barrier disruption during Japanese encephalitis virus infection. J Virol 2015; 89:5602-14.
33. Baron R, Nemirovsky A, Harpaz I, Cohen H, Owens T, Monsonego A. IFN-gamma enhances neurogenesis in wild-type mice and in a mouse model of Alzheimer's disease. FASEB J 2008; 22:2843-52.
34. Gaddi PJ, Crane MJ, Kamanaka M, Flavell RA, Yap GS, Salazar-Mather TP. IL-10 mediated regulation of liver inflammation during acute murine cytomegalovirus infection. PLoS One 2012; 7:e42850.
35. Estes ML, McAllister AK. Immune mediators in the brain and peripheral tissues in autism spectrum disorder. Nat Rev Neurosci 2015; 16:469-86.
36. Cloëtta D, Thomanetz V, Baranek C, et al. Inactivation of mTORC1 in the developing brain causes microcephaly and affects gliogenesis. J Neurosci 2013; 33:7799-810.
37. Funakoshi H, Nakamura T. Hepatocyte growth factor (HGF): neurotrophic functions and therapeutic implications for neuronal injury/diseases. Curr Signal Trans Therapy 2011; 6:156-67.
38. Molnarfi N, Benkhoucha M, Funakoshi H, Nakamura T, Lalive PH. Hepatocyte growth factor: A regulator of inflammation and autoimmunity. Autoimmun Rev 2015; 14:293-303.